-
2961
Safety and tolerability of intramuscular sotrovimab administered at different injection sites: results from the Phase 1 COSMIC study
Published 2025-12-01“…To our knowledge, these are the first data to show that a >2 mL mAb injection into each deltoid muscle is well tolerated.Trial registration ClinicalTrials.gov identifier, NCT05280717…”
Get full text
Article -
2962
Effect of Artificial Intelligence Helpfulness and Uncertainty on Cognitive Interactions with Pharmacists: Randomized Controlled Trial
Published 2025-01-01“…Trial RegistrationClinicalTrials.gov NCT06795477; https://clinicaltrials.gov/study/NCT06795477…”
Get full text
Article -
2963
Does the transition from face-to-face to face-to-screen improve oral health literacy? A non-inferiority randomized controlled trial
Published 2025-02-01“…Trial registration The trial protocol was registered in the Iranian Registry of Clinical Trials (IRCT) on 08–02-2022, (IRCT20220106053643N1|| http://www.irct.ir/ ).…”
Get full text
Article -
2964
Comparison of Healthcare Encounters and Drug Persistence in Patients With Pulmonary Arterial Hypertension Receiving Oral Selexipag, Inhaled Iloprost, or Parenteral Treprostinil: A...
Published 2022-06-01“…**Background:** Agents targeting the prostacyclin (PGI~2~) pathway are important in managing pulmonary arterial hypertension (PAH). No head-to-head clinical trials have compared outcomes between the 3 different PGI~2~-pathway drugs most commonly available in countries with advanced healthcare: oral selexipag, inhaled iloprost, and parenteral (subcutaneous or intravenous) treprostinil. …”
Get full text
Article -
2965
Efficacy and safety of pembrolizumab in patients with advanced endometrial cancer: a systematic review and meta-analysis
Published 2025-02-01“…ObjectiveThis meta-analysis evaluated pembrolizumab monotherapy and combination therapy’s efficacy and safety in recurrent or advanced endometrial cancer (EC).MethodsWe utilized PubMed, Embase, Cochrane Library, and Web of Science databases to identify clinical trials that were used to search literature from July 2013 to July 2023 to evaluate the efficacy and safety of pembrolizumab in patients with advanced EC. …”
Get full text
Article -
2966
Real-World Clinical Outcomes and Treatment Patterns Among Black and Non-Black Patients With Prostate Cancer Initiated on Apalutamide in a Urology Setting
Published 2024-08-01“…**Discussion:** While clinical trials have demonstrated the efficacy and safety of apalutamide, there is limited real-world data describing treatment persistence and clinical outcomes among patients with mCSPC and nmCRPC who initiated apalutamide. …”
Get full text
Article -
2967
Aberrant heterochromatin silences immune response genes in chronic lymphocytic leukemia
Published 2025-02-01Get full text
Article -
2968
Neuromuscular monitoring and incidence of postoperative residual neuromuscular blockade: a prospective observational study
Published 2025-01-01“…Trial registration The study was registered at ClinicalTrials.gov ( NCT06193213 , date of registration: 05/01/2024).…”
Get full text
Article -
2969
Efficacy and safety of upadacitinib in the treatment of moderate-to-severe atopic dermatitis: A systematic review.
Published 2024-01-01“…<h4>Methods</h4>PubMed, Medline, Embase, Web of Science, Clinical Trials Website, and Cochrane Library databases were searched from the time of establishment until January 6, 2024, to compile a list of all randomized controlled trials (RCTs) including upadacitinib in the treatment of moderate-to-severe AD. …”
Get full text
Article -
2970
-
2971
Complete metabolic response as early predictor of long-term efficacy after adoptive T cell therapy using tumor-infiltrating lymphocytes
Published 2025-02-01“…In this study the predictive value of early metabolic response after TIL therapy is explored.Materials and methods: 60 patients treated with TIL therapy in 4 different clinical trials and with available [18F]2-fluoro-2-deoxy-d-glucose positron emission tomography-CT (FDG-PET/CT) scans at baseline and at least one follow-up scan 6–8 weeks and/or 12–16 weeks post-TIL infusion were included.Results: Obtaining complete metabolic response (CMR) was associated with significantly superior median overall survival (mOS) compared with not obtaining CMR (p<0.0001). …”
Get full text
Article -
2972
-
2973
The Role of Cardiac Resynchronization Therapy in Heart Failure: A Narrative Review
Published 2025-01-01“…This manuscript conducted a comparative analysis various hallmark clinical trials conducted in lieu of CRT, across many years (2002, 2003, 2004, 2005, 2017, 2018, 2020). …”
Get full text
Article -
2974
-
2975
Comparison of Corneal Epitheliotrophic Factors of Undiluted Autologous Platelet-Rich Plasma and Autologous Serum Eye Drops for Dry Eye Disease
Published 2024-12-01“…Trial registration ClinicalTrials.gov identifier, NCT04683796.…”
Get full text
Article -
2976
Efficacy of Intravenous Versus Oral Administration of Levocarnitine in Maintenance Hemodialysis Patients: A Randomized Controlled Trial Investigating Therapeutic Approaches to Rena...
Published 2025-01-01“…Trial Registration ClinicalTrials.gov: NCT05817799.…”
Get full text
Article -
2977
Secondary prevention of preeclampsia
Published 2025-02-01“…Proton pump inhibitors (PPIs) have shown potential in lowering soluble FMS-like tyrosine kinase-1 (sFlt-1) levels and enhancing endothelial function, but clinical trials have been inconsistent. Metformin, primarily used for improving insulin sensitivity, has potential advantages in decreasing PE incidence due to its anti-inflammatory and vascular properties, particularly in morbidly obese women. …”
Get full text
Article -
2978
-
2979
-
2980
Comparison of the safety of remimazolam and propofol during general anesthesia in elderly patients: systematic review and meta-analysis
Published 2025-02-01“…BackgroundRemimazolam is a novel sedative drug approved for procedural sedation and general anesthesia. Clinical trials have already explored its use in elderly patients for general anesthesia. …”
Get full text
Article